首页 > 最新文献

G.E.N最新文献

英文 中文
[Use of glucomannan dietary fiber in changes in intestinal habit]. [使用葡甘露聚糖膳食纤维改变肠道习惯]。
Pub Date : 1995-01-01
L J Marsicano, M L Berrizbeitia, A Mondelo

It has been proven that fiber is effective in the treatment of multiple nosological entities, specially of the colonic pathology. In the present study, two dose of Glucomannan (3 gr/day and 4 gr/day) were evaluated within the modification of the intestinal habit and stool characteristics. 60 patients were included in a random, parallel, double blind, cross over trial study versus placebo. The modification of the intestinal habit was evaluated through variations of daily and weekly evacuations, appraising the stool's consistency and size, satiety after meals tiresomeness between meals, constipation, diarrhea and flatulence. An increase in the number of daily and weekly evacuations during the Glucomannan vs placebo treatment was appreciated and, between the two dose of Glucomannan, a difference was observed as to the large the dose, the large the number of daily and weekly evacuations. Evacuations during the phase of Glucomannan 3 gr/day increased 0.5 times per day, 3 more per week above baseline values. On the 4 gr/day treatment of Glucomannan evacuations increased 0.9 times per day, 6 more per week above baseline values. Patient during the placebo period presented no statistically significant different. No difference was appreciated as to post-meal satiety, nor tiresomeness between meals, possibly due to treatment periods being 5 weeks long. No larger number of cases with diarrhea or flatulence were appreciated with the use of Glucomannan. Glucomannan proved to be superior to placebo, and the 3 gr/day and 4 gr/day doses turned out to beneficial in the improvement of the assessed parameters--better results were obtained using 4 gr/day of Glucomannan than 3 gr/day.

事实证明,纤维对多种疾病的治疗是有效的,特别是结肠病理。在本研究中,评估了两种剂量的葡甘露聚糖(3克/天和4克/天)对肠道习惯和粪便特征的改变。60名患者被纳入一项随机、平行、双盲、交叉试验研究,与安慰剂对照。肠道习惯的改变通过每日和每周排便的变化来评估,评估大便的稠度和大小,饭后饱腹感,两餐之间的疲倦感,便秘,腹泻和胀气。在葡甘露聚糖与安慰剂治疗期间,每日和每周排出的数量有所增加,并且在两种剂量的葡甘露聚糖之间,观察到剂量越大,每日和每周排出的数量越大。在葡甘露聚糖3克/天的排泄阶段,每天增加0.5倍,每周比基线值多3次。在4克/天的治疗中,葡萄糖甘露聚糖的排出量每天增加0.9倍,每周比基线值多6倍。患者在安慰剂期无统计学差异。餐后饱腹感和两餐之间的疲倦感没有差异,这可能是由于治疗时间长达5周。使用葡甘露聚糖后,腹泻或肠胃胀气的病例没有增加。葡甘露聚糖被证明优于安慰剂,3克/天和4克/天的剂量在改善评估参数方面是有益的——4克/天的葡甘露聚糖比3克/天的效果更好。
{"title":"[Use of glucomannan dietary fiber in changes in intestinal habit].","authors":"L J Marsicano,&nbsp;M L Berrizbeitia,&nbsp;A Mondelo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>It has been proven that fiber is effective in the treatment of multiple nosological entities, specially of the colonic pathology. In the present study, two dose of Glucomannan (3 gr/day and 4 gr/day) were evaluated within the modification of the intestinal habit and stool characteristics. 60 patients were included in a random, parallel, double blind, cross over trial study versus placebo. The modification of the intestinal habit was evaluated through variations of daily and weekly evacuations, appraising the stool's consistency and size, satiety after meals tiresomeness between meals, constipation, diarrhea and flatulence. An increase in the number of daily and weekly evacuations during the Glucomannan vs placebo treatment was appreciated and, between the two dose of Glucomannan, a difference was observed as to the large the dose, the large the number of daily and weekly evacuations. Evacuations during the phase of Glucomannan 3 gr/day increased 0.5 times per day, 3 more per week above baseline values. On the 4 gr/day treatment of Glucomannan evacuations increased 0.9 times per day, 6 more per week above baseline values. Patient during the placebo period presented no statistically significant different. No difference was appreciated as to post-meal satiety, nor tiresomeness between meals, possibly due to treatment periods being 5 weeks long. No larger number of cases with diarrhea or flatulence were appreciated with the use of Glucomannan. Glucomannan proved to be superior to placebo, and the 3 gr/day and 4 gr/day doses turned out to beneficial in the improvement of the assessed parameters--better results were obtained using 4 gr/day of Glucomannan than 3 gr/day.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"49 1","pages":"7-14"},"PeriodicalIF":0.0,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19546713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endoscopic retrograde cholangiopancreatography in hepatic fascioliasis]. [内镜逆行胰胆管造影在肝筋膜吸虫病中的应用]。
Pub Date : 1994-10-01
C Tombazzi, S Abdul Hadi, V Lecuna, R Contreras, D Marquez

We present a 60 years old female with a history of upper right quadrant pain, fever and eosinophily. We made the diagnosis of fasciolasis on clinical, parasitology studies and radiological findings. In the endoscopic retrograde cholangiopancreatography (ERCP) we found the bile duct of normal caliber, but with many filling defects. Fasciola eggs were found in the bile. This is the first case with endoscopic retrograde cholanglopancreatography and the fourth case of fasciolasis in Venezuela.

我们提出一个60岁的女性与历史的右上象限疼痛,发烧和嗜酸性粒细胞增多。我们根据临床、寄生虫学研究和放射学结果诊断为片形虫病。内窥镜逆行胆管造影(ERCP)发现胆管口径正常,但有许多充盈缺陷。在胆汁中发现片形吸虫卵。这是委内瑞拉第一例内窥镜逆行胆管胰造影和第4例片吸虫病。
{"title":"[Endoscopic retrograde cholangiopancreatography in hepatic fascioliasis].","authors":"C Tombazzi,&nbsp;S Abdul Hadi,&nbsp;V Lecuna,&nbsp;R Contreras,&nbsp;D Marquez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We present a 60 years old female with a history of upper right quadrant pain, fever and eosinophily. We made the diagnosis of fasciolasis on clinical, parasitology studies and radiological findings. In the endoscopic retrograde cholangiopancreatography (ERCP) we found the bile duct of normal caliber, but with many filling defects. Fasciola eggs were found in the bile. This is the first case with endoscopic retrograde cholanglopancreatography and the fourth case of fasciolasis in Venezuela.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"278-80"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18564019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents]. [重组α - 2b干扰素治疗儿童和青少年乙型肝炎慢性活动性的长期研究]。
Pub Date : 1994-10-01
C Castañeda Guillot, M D Escobar Capote, E García Bacallao, E Borbolla Bousquets

To assess the efficacy of recombinant alfa 2b-interferon treatment "Heberon alfa R" in children with chronic active hepatitis (CAH) B virus, we conducted a long-term study (three years) in 22 children infected with hepatitis B virus (17 males and 5 females), age range 3 to 15 years. Diagnostic criteria included the clinical picture, laboratory tests, virus markers (HBeAg, HBsAg), laparoscopy and liver biopsy. Children under 12 years received 3 million IU of interferon per day whereas those older than 12 years received 6 million IU of interferon per day by intramuscular injection, three times per week for four months. Alanine aminotransferase (ALT) levels had been elevated for six months in all patients and hepatitis B viral infection was replicative. A variance analysis was made to evaluate ALT response to interferon administration and the Mc Nemar test was used to analyze HBeAg/anti-HBe behavior. Seventeen (77%) out of 22 patients responded to treatment (clearance of HBeAg and ALT levels returned to normal. HBeAg seroconversion (anti-HBe) occurred in 36% of patients during the first year (p < 0.01) and it increased to 50% by the third year follow-up. ALAT levels also decreased and the difference was statistically significant (p < 0.01). This occurred during and after treatment with a steady and increasing tendency to return to normal levels within the first and third year. Side effects were scarce, transient and tolerable and they only appeared during the initial phase of treatment; symptoms were mainly influenza-like and they disappeared very soon. There were no late side effects such as medullar depression, renal toxicity and glycemia alterations.(ABSTRACT TRUNCATED AT 250 WORDS)

为了评估重组α - 2b-干扰素治疗“Heberon α - R”对慢性活动性乙型肝炎(CAH)病毒儿童的疗效,我们对22名感染乙型肝炎病毒的儿童(17名男性,5名女性)进行了一项为期3年的长期研究,年龄范围为3至15岁。诊断标准包括临床表现、实验室检查、病毒标志物(HBeAg、HBsAg)、腹腔镜检查和肝活检。12岁以下的儿童每天接受300万IU的干扰素,而12岁以上的儿童每天接受600万IU的干扰素肌肉注射,每周3次,持续4个月。所有患者的丙氨酸转氨酶(ALT)水平升高6个月,乙型肝炎病毒感染是复制性的。用方差分析评估ALT对干扰素的反应,用mcnemar检验分析HBeAg/anti-HBe行为。22例患者中有17例(77%)对治疗有反应(HBeAg清除率和ALT水平恢复正常)。HBeAg血清转换(抗- hbe)在第一年发生在36%的患者中(p < 0.01),到第三年随访时增加到50%。ALAT水平也降低,差异有统计学意义(p < 0.01)。这种情况发生在治疗期间和治疗后,在第一和第三年内有稳定和增加的趋势恢复到正常水平。副作用少、短暂、可耐受,仅在治疗初期出现;症状以流感样为主,并很快消失。没有晚期副作用,如髓质抑制、肾毒性和血糖改变。(摘要删节250字)
{"title":"[Long term study of the treatment with recombinant alfa 2b interferon in chronic active hepatitis due to B virus in children and adolescents].","authors":"C Castañeda Guillot,&nbsp;M D Escobar Capote,&nbsp;E García Bacallao,&nbsp;E Borbolla Bousquets","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To assess the efficacy of recombinant alfa 2b-interferon treatment \"Heberon alfa R\" in children with chronic active hepatitis (CAH) B virus, we conducted a long-term study (three years) in 22 children infected with hepatitis B virus (17 males and 5 females), age range 3 to 15 years. Diagnostic criteria included the clinical picture, laboratory tests, virus markers (HBeAg, HBsAg), laparoscopy and liver biopsy. Children under 12 years received 3 million IU of interferon per day whereas those older than 12 years received 6 million IU of interferon per day by intramuscular injection, three times per week for four months. Alanine aminotransferase (ALT) levels had been elevated for six months in all patients and hepatitis B viral infection was replicative. A variance analysis was made to evaluate ALT response to interferon administration and the Mc Nemar test was used to analyze HBeAg/anti-HBe behavior. Seventeen (77%) out of 22 patients responded to treatment (clearance of HBeAg and ALT levels returned to normal. HBeAg seroconversion (anti-HBe) occurred in 36% of patients during the first year (p < 0.01) and it increased to 50% by the third year follow-up. ALAT levels also decreased and the difference was statistically significant (p < 0.01). This occurred during and after treatment with a steady and increasing tendency to return to normal levels within the first and third year. Side effects were scarce, transient and tolerable and they only appeared during the initial phase of treatment; symptoms were mainly influenza-like and they disappeared very soon. There were no late side effects such as medullar depression, renal toxicity and glycemia alterations.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"219-25"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18564738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Macroscopic and histopathological aspects of atypical gastric epithelium]. [非典型胃上皮的宏观和组织病理学方面]。
Pub Date : 1994-10-01
D Castro, E Cano, S Peraza, W Oliver, V Sánchez, O Andrade, G López, R García, J Vivas

Atypical Epithelium is a localized lesion, which has histological and macroscopic findings similar to gastric cancer. In this paper we evaluated 44 cases of atypical epithelium studied and treated in our institute. We found 3 cases of atypical epithelium associated with early gastric cancer. That is 2.66% of the total of all cases. We established the relationship of these lesions and following variables: age, size, localization, macroscopic shape and intestinal metaplasia. We found atypical epithelium in patients older than 50 years old, most of then smaller than 2 cm., localized in antrum and body gastric, and macroscopically were slight elevated lesions. Histologically all of them had intestinal metaplasia.

不典型上皮是一种局部病变,其组织学和宏观表现与胃癌相似。本文对我院研究治疗的44例非典型上皮进行了评价。我们发现3例与早期胃癌相关的不典型上皮。这占所有病例总数的2.66%。我们建立了这些病变与以下变量的关系:年龄,大小,定位,宏观形状和肠化生。我们在50岁以上的患者中发现不典型上皮,大多数小于2厘米。胃窦及胃体病变,肉眼可见轻度升高。组织学上均有肠化生。
{"title":"[Macroscopic and histopathological aspects of atypical gastric epithelium].","authors":"D Castro,&nbsp;E Cano,&nbsp;S Peraza,&nbsp;W Oliver,&nbsp;V Sánchez,&nbsp;O Andrade,&nbsp;G López,&nbsp;R García,&nbsp;J Vivas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Atypical Epithelium is a localized lesion, which has histological and macroscopic findings similar to gastric cancer. In this paper we evaluated 44 cases of atypical epithelium studied and treated in our institute. We found 3 cases of atypical epithelium associated with early gastric cancer. That is 2.66% of the total of all cases. We established the relationship of these lesions and following variables: age, size, localization, macroscopic shape and intestinal metaplasia. We found atypical epithelium in patients older than 50 years old, most of then smaller than 2 cm., localized in antrum and body gastric, and macroscopically were slight elevated lesions. Histologically all of them had intestinal metaplasia.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"232-5"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18564741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Complications of laparoscopic cholecystectomy]. [腹腔镜胆囊切除术并发症]。
Pub Date : 1994-10-01
C Tombazzi, B Lander, R Bacalao, D Marquez, V Lecuna

The laparoscopy cholecistectomy is a surgical procedure described in 1987, and it has had an important apogee and it's had substitute to open procedure. Between its advantages is notable, the postoperatory evolution without pain, paralytic ileus and the short time of hospitalization besides the patient can go away the same day in some cases. In Venezuela, the procedure has been received with enthusiasm by the surgeons with prefer this procedure however, there are complications derived in part for the lack of experience in the first cases, but occur non related of the experience. The quantization of the complications is not simple to realize for different reasons. We present twelve complications, two belong to patients intervened in the Hospital Universitario de Caracas and ten belong to patient transferred from other center. The complications were: pseudoaneurism of hepatic artery, hematoma of the wall, cutting of common bile duct, section the right bile duct, abscess of vesicular bed in two cases, retropneumoperitoneum, ascites by biliary fistula and four biloma. The treatment varied in every case and the utilization of radiologic technique with percutaneous drainage were useful in five cases. We conclude: first, this technique is not free of complications. Second, the percutaneous drainage (abscess, biloma), endoscopic procedure (biliary prosthesis) in fistulaes and arteriographics (arterial embolization), are useful in some cases, and could prevent the surgical reintervention.

腹腔镜胆囊切除术是1987年描述的一种外科手术,它有一个重要的最高点它可以替代开腹手术。其优点之间是显著的,术后进化无疼痛,麻痹性肠梗阻,住院时间短,除此之外,患者在某些情况下可当日出院。在委内瑞拉,这种手术受到了外科医生的热情欢迎,他们更喜欢这种手术。然而,在第一次手术中,由于缺乏经验,出现了一些并发症,但这些并发症的发生与经验无关。由于各种原因,复杂性的量化并不容易实现。我们报告了12例并发症,其中2例属于在加拉加斯大学医院干预的患者,10例属于从其他中心转移的患者。并发症有:肝动脉假性动脉瘤、肝壁血肿、胆总管切开、右侧胆管切断术、囊床脓肿2例、肾后气腹、胆道瘘腹水、胆囊瘤4例。治疗方法各不相同,其中5例采用经皮引流的放射技术。我们得出结论:首先,该技术并非没有并发症。其次,经皮引流(脓肿、胆囊瘤)、瘘管内窥镜手术(胆道假体)和动脉造影(动脉栓塞)在某些情况下是有用的,可以防止手术再干预。
{"title":"[Complications of laparoscopic cholecystectomy].","authors":"C Tombazzi,&nbsp;B Lander,&nbsp;R Bacalao,&nbsp;D Marquez,&nbsp;V Lecuna","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The laparoscopy cholecistectomy is a surgical procedure described in 1987, and it has had an important apogee and it's had substitute to open procedure. Between its advantages is notable, the postoperatory evolution without pain, paralytic ileus and the short time of hospitalization besides the patient can go away the same day in some cases. In Venezuela, the procedure has been received with enthusiasm by the surgeons with prefer this procedure however, there are complications derived in part for the lack of experience in the first cases, but occur non related of the experience. The quantization of the complications is not simple to realize for different reasons. We present twelve complications, two belong to patients intervened in the Hospital Universitario de Caracas and ten belong to patient transferred from other center. The complications were: pseudoaneurism of hepatic artery, hematoma of the wall, cutting of common bile duct, section the right bile duct, abscess of vesicular bed in two cases, retropneumoperitoneum, ascites by biliary fistula and four biloma. The treatment varied in every case and the utilization of radiologic technique with percutaneous drainage were useful in five cases. We conclude: first, this technique is not free of complications. Second, the percutaneous drainage (abscess, biloma), endoscopic procedure (biliary prosthesis) in fistulaes and arteriographics (arterial embolization), are useful in some cases, and could prevent the surgical reintervention.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"245-9"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18562861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Intestinal microflora in children with acute and persistent diarrhea]. [儿童急性持续性腹泻的肠道菌群分析]。
Pub Date : 1994-10-01
Y García Cristia, T Fragoso Arbelo, M Valdés-Dapena Vivanca, E Sagaro González, N Gorrín Castellanos

The etiology and pathogenesis of persistent diarrhoea is usually multifactorial and sometimes can not be identified. It is necessary to define if an alteration of the enteric microflora is a risk factor that influence the duration of the diarrhoea. 30 infants with acute diarrhoea and 30 with persistent diarrhoea were studied. A sample of duodenal content was taken by a doble-lumen tube and processed microbiologically in search for enteric microorganisms, anaerobic and Candida. These result were correlated with nutritional status, the previous use of Metroonidazol and the results of the stool culture. The presence of bacterial overgrowth and the identification of the duodenal microflora is an important factor for the persistence of the diarrhoea. There was a quantitative and qualitative alteration of the duodenal flora in both groups of patients.

持续性腹泻的病因和发病机制通常是多因素的,有时无法确定。有必要确定肠道菌群的改变是否是影响腹泻持续时间的危险因素。对30例急性腹泻患儿和30例持续性腹泻患儿进行了研究。采用双腔管采集十二指肠内容物样本,进行微生物学处理,寻找肠道微生物、厌氧菌和念珠菌。这些结果与营养状况、既往使用甲硝唑和粪便培养结果有关。细菌过度生长的存在和十二指肠菌群的鉴定是腹泻持续存在的重要因素。两组患者的十二指肠菌群在数量和质量上都有改变。
{"title":"[Intestinal microflora in children with acute and persistent diarrhea].","authors":"Y García Cristia,&nbsp;T Fragoso Arbelo,&nbsp;M Valdés-Dapena Vivanca,&nbsp;E Sagaro González,&nbsp;N Gorrín Castellanos","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The etiology and pathogenesis of persistent diarrhoea is usually multifactorial and sometimes can not be identified. It is necessary to define if an alteration of the enteric microflora is a risk factor that influence the duration of the diarrhoea. 30 infants with acute diarrhoea and 30 with persistent diarrhoea were studied. A sample of duodenal content was taken by a doble-lumen tube and processed microbiologically in search for enteric microorganisms, anaerobic and Candida. These result were correlated with nutritional status, the previous use of Metroonidazol and the results of the stool culture. The presence of bacterial overgrowth and the identification of the duodenal microflora is an important factor for the persistence of the diarrhoea. There was a quantitative and qualitative alteration of the duodenal flora in both groups of patients.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"236-44"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18562864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hepatic tolerance of aceclofenac]. [乙酰氯芬酸肝耐受]。
Pub Date : 1994-10-01
L J Marsicano, M E Ocampo

NSAID's are largely used drugs. Among the reported side effects of this type of drugs is liver damage. 73 patients suffering from diverse rheumatological pathologies (arthrosis 46.6%, rotators 9.68%, rheumatoid arthritis 21.92%, lumbalgia 5.48%, other diagnosis 6.85%) were evaluated. Aceclofenac (AC) 100 mg. dose every 12 hours was administered. A Transaminase value determination was taken both at the beginning and end of medication for each patient. Average age of patients was 52.71 years, 78% being female. Treatment was administered as follows, 42.47% of the patients received a 60 days treatment, 28.8% a 45 days treatment, 23.3% a 30 days treatment and 5.47% received a 15 days treatment. Reported mean GOT value at the beginning was 16.6 U, at the end 17.01 U. GPT initial value was 15.84 U and final 16.53 U. A GOT increase, 20 U to 50 was observed in a single patient. GPT was also increased from 32 U to 47 U in one case. Results led us to a no liver damage report of the NSAID's AC in these group of patients.

非甾体抗炎药是一种大量使用的药物。据报道,这类药物的副作用之一是肝损伤。73例不同类型风湿病的患者(关节病46.6%,旋转病9.68%,类风湿性关节炎21.92%,腰痛5.48%,其他诊断6.85%)进行了评估。乙酰氯芬酸(AC) 100mg。每12小时给药一次。在每个患者用药开始和结束时进行转氨酶值测定。患者平均年龄52.71岁,女性占78%。治疗方案:60 d占42.47%,45 d占28.8%,30 d占23.3%,15 d占5.47%。GPT初始值为15.84 U,最终值为16.53 U,单例患者GPT升高20 ~ 50 U。其中一例GPT也从32 U增加到47 U。结果表明,在这组患者中,非甾体抗炎药AC无肝损害报告。
{"title":"[Hepatic tolerance of aceclofenac].","authors":"L J Marsicano,&nbsp;M E Ocampo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>NSAID's are largely used drugs. Among the reported side effects of this type of drugs is liver damage. 73 patients suffering from diverse rheumatological pathologies (arthrosis 46.6%, rotators 9.68%, rheumatoid arthritis 21.92%, lumbalgia 5.48%, other diagnosis 6.85%) were evaluated. Aceclofenac (AC) 100 mg. dose every 12 hours was administered. A Transaminase value determination was taken both at the beginning and end of medication for each patient. Average age of patients was 52.71 years, 78% being female. Treatment was administered as follows, 42.47% of the patients received a 60 days treatment, 28.8% a 45 days treatment, 23.3% a 30 days treatment and 5.47% received a 15 days treatment. Reported mean GOT value at the beginning was 16.6 U, at the end 17.01 U. GPT initial value was 15.84 U and final 16.53 U. A GOT increase, 20 U to 50 was observed in a single patient. GPT was also increased from 32 U to 47 U in one case. Results led us to a no liver damage report of the NSAID's AC in these group of patients.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"250-5"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18562868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adenosquamous carcinoma of the colon]. [结肠腺鳞癌]。
Pub Date : 1994-10-01
N C Betancourt
{"title":"[Adenosquamous carcinoma of the colon].","authors":"N C Betancourt","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"281"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18564015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Morphology of Blastocystis hominis in feces and evaluation of parasitological methods]. [粪便中人芽囊虫的形态及寄生虫学方法的评价]。
Pub Date : 1994-10-01
E Peréz de Suarez, C Guzmán de Rondón

A study of the morphology of Blastocystis hominis in stool in ninety-four cases humans is described as central body, ameba and granular form were found as previously described. In addition a "Globulose" form as a variation of granular form is first described. The central body form (96.8%) was the most abundant form. Three parasitological methods as direct microscopical examination sample with saline solution 0.85%, lugol, Sudan III, stained with Quensel, Iron hematoxylin and culture are evaluated to detection the Blastocystis hominis forms. Our results show that the direct microscopical examination (saline solution 0.85%, lugol, Sudan III, stained with Quensel) is the most sensitive and specific method than culture. The identification of Blastocystis hominis in stool difficult due to the diversity of shapes and size, which generate confusion with other intestinal protozoa and host cells.

对94例人类粪便中人类囊虫的形态进行了研究,描述为中心体,阿米巴和颗粒状,如前所述。此外,首先描述了“球状”形式作为颗粒形式的一种变体。以中心体型(96.8%)最多。采用生理盐水0.85%、lugol、Sudan III、Quensel染色法、苏木精铁染色法和培养法检测人芽囊原虫。结果表明,直接镜检法(生理盐水0.85%,lugol, Sudan III, Quensel染色)比培养法更敏感,特异性更高。由于其形状和大小的多样性,使其与其他肠道原生动物和宿主细胞相混淆,因此在粪便中很难识别出人芽囊原虫。
{"title":"[Morphology of Blastocystis hominis in feces and evaluation of parasitological methods].","authors":"E Peréz de Suarez,&nbsp;C Guzmán de Rondón","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A study of the morphology of Blastocystis hominis in stool in ninety-four cases humans is described as central body, ameba and granular form were found as previously described. In addition a \"Globulose\" form as a variation of granular form is first described. The central body form (96.8%) was the most abundant form. Three parasitological methods as direct microscopical examination sample with saline solution 0.85%, lugol, Sudan III, stained with Quensel, Iron hematoxylin and culture are evaluated to detection the Blastocystis hominis forms. Our results show that the direct microscopical examination (saline solution 0.85%, lugol, Sudan III, stained with Quensel) is the most sensitive and specific method than culture. The identification of Blastocystis hominis in stool difficult due to the diversity of shapes and size, which generate confusion with other intestinal protozoa and host cells.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"226-31"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18564740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Autoimmune diseases of the liver. Autoimmune hepatitis]. 肝脏自身免疫性疾病自身免疫性肝炎)。
Pub Date : 1994-10-01
M A Garassini Serra, M E Garassini Chávez
{"title":"[Autoimmune diseases of the liver. Autoimmune hepatitis].","authors":"M A Garassini Serra,&nbsp;M E Garassini Chávez","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"48 4","pages":"256-63"},"PeriodicalIF":0.0,"publicationDate":"1994-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18562862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
G.E.N
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1